On February 1, 2017 Leede Jones Gable Inc. entered into a finder’s agreement with Acasti Pharma Inc. (“Acasti”) in connection with a proposed private placement of $2 million aggregate principal amount of unsecured convertible debentures and warrants to acquire Class A shares of Acasti, with arm’s length investors (collectively, the “Private Placement”).

In part, the Private Placement is intended to provide a comprehensive financing package to fund Acasti’s operations until December 31, 2017, through the completion of the manufacturing scale-up and planning for the Phase 3 clinical trial for the continued development of CaPre®.

Leede Jones Gable is one of Canada’s leading independent investment dealers, providing a full range of investment products and services to clients all across Canada.

Peterson McVicar acted for Leede Jones Gable Inc. with a team that included Dennis Peterson.